DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress

Chia-Yih Wang, E. Y.H. Huang, S. C. Huang, B. C. Chung

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk)2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.

Original languageEnglish
Pages (from-to)1263-1269
Number of pages7
JournalOncogene
Volume34
Issue number10
DOIs
Publication statusPublished - 2015 Mar 5

Fingerprint

DNA-Activated Protein Kinase
Ataxia Telangiectasia
Centrosome
Hydroxyurea
Centrioles
Checkpoint Kinase 2
Neoplasms
Genomic Instability
DNA
Aneuploidy
Mitosis
Antineoplastic Agents
Cell Death
Phosphorylation
Recurrence
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Wang, Chia-Yih ; Huang, E. Y.H. ; Huang, S. C. ; Chung, B. C. / DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress. In: Oncogene. 2015 ; Vol. 34, No. 10. pp. 1263-1269.
@article{fa3d1c5faeaf4aa0ac5768b6f89a9b40,
title = "DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress",
abstract = "The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk)2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.",
author = "Chia-Yih Wang and Huang, {E. Y.H.} and Huang, {S. C.} and Chung, {B. C.}",
year = "2015",
month = "3",
day = "5",
doi = "10.1038/onc.2014.74",
language = "English",
volume = "34",
pages = "1263--1269",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "10",

}

DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress. / Wang, Chia-Yih; Huang, E. Y.H.; Huang, S. C.; Chung, B. C.

In: Oncogene, Vol. 34, No. 10, 05.03.2015, p. 1263-1269.

Research output: Contribution to journalArticle

TY - JOUR

T1 - DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress

AU - Wang, Chia-Yih

AU - Huang, E. Y.H.

AU - Huang, S. C.

AU - Chung, B. C.

PY - 2015/3/5

Y1 - 2015/3/5

N2 - The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk)2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.

AB - The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk)2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84896408438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896408438&partnerID=8YFLogxK

U2 - 10.1038/onc.2014.74

DO - 10.1038/onc.2014.74

M3 - Article

C2 - 24662822

AN - SCOPUS:84896408438

VL - 34

SP - 1263

EP - 1269

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -